Ignite Creation Date:
2024-05-06 @ 3:02 PM
Last Modification Date:
2024-10-26 @ 1:42 PM
Study NCT ID:
NCT04505449
Status:
COMPLETED
Last Update Posted:
2022-10-27
First Post:
2020-08-06
Brief Title:
Invasive Left Heart Catheterization Registry
Sponsor:
Samsung Medical Center
Organization:
Samsung Medical Center
Study Overview
Official Title:
Role of Invasive Left Heart Catheterization for Patients Suspected Heart Failure With Preserved Ejection Fraction
Status:
COMPLETED
Status Verified Date:
2022-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Retrospectively enrolled suspicious of heart failure with preserved ejection fraction HFpEF patients who underwent left heart catheterization with the measurement of left ventricular end-diastolic pressure
Detailed Description:
Heart failure HF with preserved ejection fraction HFpEF remains a poorly understood clinical syndrome without effective targeted therapies The clinical syndrome of HFpEF develops from a complex interaction of several risk factors such as aging obesity hypertension myocardial ischemia and arterial stiffness that cause organ dysfunction and ultimately clinical symptoms Although the H2FPEF and HFA-PEFF scores have recently been proposed to estimate the probability of HFpEF in patients suffering from unexplained dyspnea diagnosing HFpEF remains still challenging The aim of the current registry was to evaluate the role of invasive left heart catheterization with the measurement of left ventricular end-diastolic pressure LVEDP in suspicious of HFpEF patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None